Showing 11,721 - 11,740 results of 32,495 for search '(( 50 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.11s Refine Results
  1. 11721

    Table 1_Association of the ROX index with mortality in sepsis patients: a retrospective study.docx by Jiali Wu (701228)

    Published 2025
    “…Restricted cubic spline analysis revealed a nonlinear “L”-shaped association, with the 28-day mortality risk decreasing until reaching a plateau at a ROX index of approximately 10.50. …”
  2. 11722

    DataSheet1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.docx by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  3. 11723

    Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease by Yagahira E. Castro-Sesquen (284439)

    Published 2014
    “…The nanoparticles concentrate <i>T. cruzi</i> antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%–98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%–57.26%). …”
  4. 11724
  5. 11725

    Lactadherin Inhibits Secretory Phospholipase A<sub>2</sub> Activity on Pre-Apoptotic Leukemia Cells by Steffen Nyegaard (475969)

    Published 2013
    “…Inhibition of human secretory phospholipase A<sub>2</sub>-V on phospholipid vesicles exceeded 90%, whereas inhibition of <i>Naja mossambica</i> sPLA<sub>2</sub> plateaued at 50–60%. …”
  6. 11726

    DataSheet1_A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center,... by Anju Majeed (19169428)

    Published 2024
    “…WOMAC pain (70.2%, 73.9%, WOMAC stiffness (65.6%,68.9%), WOMAC function (68.8%,74.2%), LFI severity (50%,53.3%), decreased and EQ5D (56.9%, 62.9%) and distance walked in 6 minutes (21.2%, 21.9%) improved in the BSE-150 and BSE-300 groups in 90 days. …”
  7. 11727

    Effect of Peer Health Workers on AIDS Care in Rakai, Uganda: A Cluster-Randomized Trial by Larry W. Chang (247945)

    Published 2010
    “…</p><h3>Conclusions/Significance</h3><p>A PHW intervention was associated with decreased virologic failure rates occurring 96 weeks and longer into ART, but did not affect cumulative risk of virologic failure, adherence measures, or shorter-term virologic outcomes. …”
  8. 11728

    Liver peliosis-like phenotype and thymus degeneration are associated with the doxycycline-induced overall VEGF-A-164 expression in adult pCAGGS-Cre, ROSA26-rtTA-IRES-EGFP, --VEGF-A... by Gusztav Belteki (58903)

    Published 2011
    “…(A, D, G and J), 50× magnification; (B and E), 125× magnification; (H and K), 250× magnification; and (C, F, I and L), 500× magnification.…”
  9. 11729

    Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population by Zhen-Yu Zhang (458621)

    Published 2016
    “…E/e’ decreased with uCIII by 0.168 (0.021 to 0.316; <i>p</i> = 0.018). …”
  10. 11730

    Table_4_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  11. 11731

    Table_2_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.XLSX by Jan Vollert (5099921)

    Published 2022
    “…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”
  12. 11732

    Table_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  13. 11733

    Table_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  14. 11734

    Table_1_Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.xlsx by Jan Vollert (5099921)

    Published 2022
    “…Background<p>Irritable bowel syndrome (IBS) is a highly prevalent chronic pain disorder with multiple underlying mechanisms and few treatments that have been demonstrated to be effective in placebo controlled trials. …”
  15. 11735

    Image_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  16. 11736

    Table_3_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  17. 11737

    Apoptosis inhibition by <i>Simkania</i> is a function of time and infection dose and is independent of the stimulus. by Karthika Karunakaran (212688)

    Published 2011
    “…<p>(<b>A</b>) Immunofluorescence analysis of the time and dose dependency of <i>Simkania</i> mediated anti-apoptosis. …”
  18. 11738

    Image_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  19. 11739

    Table_5_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

    Published 2024
    “…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”
  20. 11740